A court hearing in Pennsylvania will focus on the relationship between Zoloft and birth defects. The hearing will likely affect future court cases and lawsuits involving antidepressants in a class known as selective serotonin reuptake inhibitors (SSRIs). Several experts will give testimony at the hearing.
Zoloft birth defects have become a primary concern for pregnant women who suffer from depression. Studies show an increased risk of severe birth defects among children born to women who use Zoloft during pregnancy — especially during the third trimester.
Zoloft is one of the top-selling antidepressants in the world, with tens of millions of prescriptions for the drug written every year. A 2006 study found that women who use the Zoloft during pregnancy are 6 times more likely to have a child who suffers from persistent pulmonary hypertension of the newborn (PPHN). Other Zoloft birth defects include heart defects, brain defects, omphalocele, anencephaly and other congenital birth defects.